Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer

Hepato-gastroenterology

Volumn 61, Issue 131, 2014, Pages 599-605

  Kasuya, Hideki ^a   Kodera, Yasuhiro ^a   Nakao, Akimasa ^a   Yamamura, Kazuo ^a   Gewen, Tan ^a   Zhiwen, Wu ^a   Hotta, Yoshihiro ^a   Yamada, Suguru ^a   Fujii, Tsutomu ^a   Fukuda, Saori ^a   Tsurumaru, Naoko ^a   Kuwahara, Toshie ^a   Kikumori, Toyone ^a   Koide, Yusuke ^a   Fujimoto, Yasushi ^a   Nakashima, Tsutomu ^a   Hirooka, Yoshiki ^a   Shiku, Hiroshi ^a   Tanaka, Maki ^a   Takesako, Kazuto ^a   Kondo, Touru ^a   Aleksic, Branko ^a   Kawashima, Hiroki ^a   Goto, Hidemi ^a   Nishiyama, Yukihiro ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

ADVERSE EFFECTS; CANCER STAGING; CLINICAL TRIAL; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX VIRUS 1; HUMAN; JAPAN; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; ONCOLYTIC VIROTHERAPY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PROCEDURES; TIME; TREATMENT OUTCOME; VIROLOGY; VIRUS REPLICATION;

FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; TIME FACTORS; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 84938937360     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)